News
Malnutrition-related diabetes—typically affecting lean, malnourished teens and young adults in low- and middle-income countries—is now officially recognized as a distinct form of the disease, known as ...
A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute of Infectious Diseases in collaboration with scientists from the Albert ...
While it is understood that the drugs have also proven to be safe and effective for thousands, the negative issues have led ...
The American Academy of Dermatology has announced the results of its annual election. The Academy’s new officers and board members will lead the world’s largest dermatologic society, representing more ...
For graduating medical students across the country, Friday, March 21 was Match Day. The CMU College of Medicine Class of 2025 gathered to celebrate with their families, friends, faculty and staff ...
A new PBS documentary follows eight medical students from diverse backgrounds attending the Albert Einstein College of Medicine in Morris Park, giving viewers a glimpse into the grueling journey from ...
TALLAHASSEE — New College of Florida could take over the University of South Florida’s Sarasota-Manatee campus under plans being negotiated in the state Legislature, according to a top ...
This early-stage finding is at odds with the current theory which was developed in part by Albert Einstein ... from University College London, are being swept up by the mounting evidence.
Prime Medicine announces promising preclinical results for a novel AATD treatment using advanced Prime Editing technology, aiming for clinical trials by mid-2026. Prime Medicine, Inc. announced ...
Albert C. Barnes, founder of the Barnes Foundation, was too large a character to be restrained by mortality. He and his collection have been the subject of a documentary and books, and the terms of ...
-- Prime Editing has potential to be best-in-class approach for AATD -- -- Previously undisclosed program now emerging from within liver platform; leverages proprietary, universal liver LNP ...
CAMBRIDGE, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results